311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster III
0 activities
"Platelet Variability Index As a Diagnostic Tool in Primary Immune Thrombocytopenia: Findings from a Cohort Study"
1 activities
"Platelet Variability Index As a Diagnostic Tool in Primary Immune Thrombocytopenia: Findings from a Cohort Study"
Clinical Burden of Illness in Patients with Persistent or Chronic Primary Immune Thrombocytopenia Treated with Advanced Therapies in the United States
1 activities
Clinical Burden of Illness in Patients with Persistent or Chronic Primary Immune Thrombocytopenia Treated with Advanced Therapies in the United States
Clinical Study to Determine the Pathogenesis of Autoimmune Thrombocytopenia in Pediatric Patients
1 activities
Clinical Study to Determine the Pathogenesis of Autoimmune Thrombocytopenia in Pediatric Patients
Impact of Intravenous Immunoglobulin (IVIG) on Venous Thromboembolism/Pulmonary Embolism in Immune Thrombocytopenic Purpura- an NIS 2020 Database Analysis
1 activities
Impact of Intravenous Immunoglobulin (IVIG) on Venous Thromboembolism/Pulmonary Embolism in Immune Thrombocytopenic Purpura- an NIS 2020 Database Analysis
Impact of Platelet Transfusion and Bleeding Risk Stratification in Patients with Immune Thrombocytopenia before Procedures: A Nationwide Population-Based Cohort Study
1 activities
Impact of Platelet Transfusion and Bleeding Risk Stratification in Patients with Immune Thrombocytopenia before Procedures: A Nationwide Population-Based Cohort Study
Incidence of ITP before and after COVID-19: A Nationwide Inpatient Sample Study
1 activities
Incidence of ITP before and after COVID-19: A Nationwide Inpatient Sample Study
Investigating the Effectiveness and Safety of Combining Thrombopoietin Receptor Agonist and Immunosuppressant Drugs for Patients with Multirefractory Immune Thrombocytopenia after Second-Line Monotherapy Treatments
1 activities
Investigating the Effectiveness and Safety of Combining Thrombopoietin Receptor Agonist and Immunosuppressant Drugs for Patients with Multirefractory Immune Thrombocytopenia after Second-Line Monotherapy Treatments
Iron Deficiency in Immune Thrombocytopenia: Are We Doing Enough?
1 activities
Iron Deficiency in Immune Thrombocytopenia: Are We Doing Enough?
Low-Dose Corticosteroids and Eltrombopag in the Treatment of Newly Diagnosed Adult Immune Thrombocytopenia: A Multicenter, Phase 2 Clinical Trial
1 activities
Low-Dose Corticosteroids and Eltrombopag in the Treatment of Newly Diagnosed Adult Immune Thrombocytopenia: A Multicenter, Phase 2 Clinical Trial
Maternal Bleeding Complications in Pregnant Women with Immune Thrombocytopenic Purpura: A Retrospective National Study
1 activities
Maternal Bleeding Complications in Pregnant Women with Immune Thrombocytopenic Purpura: A Retrospective National Study
Obinutuzumab Is a Promising Alternative for the Treatment of Relapsed or Refractory Autoimmune Hematological Disorders
1 activities
Obinutuzumab Is a Promising Alternative for the Treatment of Relapsed or Refractory Autoimmune Hematological Disorders
Patient-Specific Platelet Phenotypes in Patients with Immune Thrombocytopenia
1 activities
Patient-Specific Platelet Phenotypes in Patients with Immune Thrombocytopenia
Platelet Laboratory Markers of Failure of First-Line Treatments in Immune Thrombocytopenia (ITP)
1 activities
Platelet Laboratory Markers of Failure of First-Line Treatments in Immune Thrombocytopenia (ITP)
Platelet Sequestration Patterns and Clearance Rates in Patients with ITP Compared to Healthy Individuals
1 activities
Platelet Sequestration Patterns and Clearance Rates in Patients with ITP Compared to Healthy Individuals
Protein Energy Malnutrition and in-Hospital Outcomes Among Hospitalized Patients with Immune Thrombocytopenia: A United States Collaborative Network Cohort Study
1 activities
Protein Energy Malnutrition and in-Hospital Outcomes Among Hospitalized Patients with Immune Thrombocytopenia: A United States Collaborative Network Cohort Study
Serum O-Glycan Antigenicity in Pediatric Immune Thrombocytopenia Predicts Disease Persistence
1 activities
Serum O-Glycan Antigenicity in Pediatric Immune Thrombocytopenia Predicts Disease Persistence
Trends and Disparities in Idiopathic Thrombocytopenic Purpura-Related Mortality in the United States: A Retrospective Study over Two Decades
1 activities
Trends and Disparities in Idiopathic Thrombocytopenic Purpura-Related Mortality in the United States: A Retrospective Study over Two Decades